On September 29, WUXI APPTEC rose 3.4% in regular trading, trading at HK$213.4/share, with turnover of HK$164 million.

On the news front, the company announced that its RMB 6.78 billion zero-coupon USD-settled convertible bonds due 2027 have been fully converted into H shares. The listing status on the Vienna Stock Exchange was officially cancelled on September 25, meaning all dilution pressure from the convertible bonds has been completely eliminated, with no outstanding bonds remaining. The conversion had been carried out in multiple tranches since early September, with cumulative issuance of tens of millions of new H shares at a conversion price of HK$153 per share.

Meanwhile, FMR LLC purchased 467,300 shares on September 22 at an average price of approximately HK$208.14 per share, totaling about HK$97.26 million, raising its stake to 10.07%. However, BlackRock reduced its position via an off-exchange transaction on September 23, lowering its good position ratio from 5.34% to 4.96%. Sector peers also traded higher, with WUXI BIO up 3.93%, INSILICO up 4.18%, and XTALPI up 3.4%, reflecting broadly positive sentiment across Life Sciences Tools and Services stocks.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)